Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Int J Neuropsychopharmacol
2014 Jun 01;176:907-16. doi: 10.1017/S1461145713001703.
Show Gene links
Show Anatomy links
Avermectins differentially affect ethanol intake and receptor function: implications for developing new therapeutics for alcohol use disorders.
Asatryan L, Yardley MM, Khoja S, Trudell JR, Hyunh N, Louie SG, Petasis NA, Alkana RL, Davies DL.
???displayArticle.abstract???
Our laboratory is investigating ivermectin (IVM) and other members of the avermectin family as new pharmaco-therapeutics to prevent and/or treat alcohol use disorders (AUDs). Earlier work found that IVM significantly reduced ethanol intake in mice and that this effect likely reflects IVM's ability to modulate ligand-gated ion channels. We hypothesized that structural modifications that enhance IVM's effects on key receptors and/or increase its brain concentration should improve its anti-alcohol efficacy. We tested this hypothesis by comparing the abilities of IVM and two other avermectins, abamectin (ABM) and selamectin (SEL), to reduce ethanol intake in mice, to alter modulation of GABAARs and P2X4Rs expressed in Xenopus oocytes and to increase their ability to penetrate the brain. IVM and ABM significantly reduced ethanol intake and antagonized the inhibitory effects of ethanol on P2X4R function. In contrast, SEL did not affect either measure, despite achieving higher brain concentrations than IVM and ABM. All three potentiated GABAAR function. These findings suggest that chemical structure and effects on receptor function play key roles in the ability of avermectins to reduce ethanol intake and that these factors are more important than brain penetration alone. The direct relationship between the effect of these avermectins on P2X4R function and ethanol intake suggest that the ability to antagonize ethanol-mediated inhibition of P2X4R function may be a good predictor of the potential of an avermectin to reduce ethanol intake and support the use of avermectins as a platform for developing novel drugs to prevent and/or treat AUDs.
Asatryan,
Ivermectin antagonizes ethanol inhibition in purinergic P2X4 receptors.
2010,
Pubmed
,
Xenbase Bortolato,
Pharmacological insights into the role of P2X4 receptors in behavioural regulation: lessons from ivermectin.
2013,
Pubmed Bouchery,
Economic costs of excessive alcohol consumption in the U.S., 2006.
2011,
Pubmed Colombo,
The cannabinoid CB1 receptor antagonist, rimonabant, as a promising pharmacotherapy for alcohol dependence: preclinical evidence.
2007,
Pubmed Crump,
Ivermectin, 'wonder drug' from Japan: the human use perspective.
2011,
Pubmed Cully,
Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans.
1994,
Pubmed
,
Xenbase Davies,
Ethanol sensitivity in ATP-gated P2X receptors is subunit dependent.
2002,
Pubmed
,
Xenbase Davies,
Ethanol differentially affects ATP-gated P2X(3) and P2X(4) receptor subtypes expressed in Xenopus oocytes.
2005,
Pubmed
,
Xenbase Dawson,
Anticonvulsant and adverse effects of avermectin analogs in mice are mediated through the gamma-aminobutyric acid(A) receptor.
2000,
Pubmed
,
Xenbase Dent,
avr-15 encodes a chloride channel subunit that mediates inhibitory glutamatergic neurotransmission and ivermectin sensitivity in Caenorhabditis elegans.
1997,
Pubmed Gewiss,
Acamprosate and diazepam differentially modulate alcohol-induced behavioural and cortical alterations in rats following chronic inhalation of ethanol vapour.
1991,
Pubmed Grant,
The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002.
2004,
Pubmed Harris,
Pharmacotherapy of alcohol use disorders in the Veterans Health Administration.
2010,
Pubmed Johnson,
Medication treatment of different types of alcoholism.
2010,
Pubmed Johnson,
Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.
2008,
Pubmed Khakh,
Allosteric control of gating and kinetics at P2X(4) receptor channels.
1999,
Pubmed
,
Xenbase Krause,
Ivermectin: a positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor.
1998,
Pubmed
,
Xenbase Krůsek,
Effect of ivermectin on gamma-aminobutyric acid-induced chloride currents in mouse hippocampal embryonic neurones.
1994,
Pubmed Lespine,
Interaction of macrocyclic lactones with P-glycoprotein: structure-affinity relationship.
2007,
Pubmed Litten,
Medications development to treat alcohol dependence: a vision for the next decade.
2012,
Pubmed Ménez,
Relative neurotoxicity of ivermectin and moxidectin in Mdr1ab (-/-) mice and effects on mammalian GABA(A) channel activity.
2012,
Pubmed
,
Xenbase Michael,
Comparison of ivermectin, doramectin, selamectin, and eleven intermediates in a nematode larval development assay.
2001,
Pubmed Naimi,
The cost of alcohol and its corresponding taxes in the U.S.: a massive public subsidy of excessive drinking and alcohol industries.
2011,
Pubmed Omura,
Ivermectin: 25 years and still going strong.
2008,
Pubmed Popova,
Tryptophan 46 is a site for ethanol and ivermectin action in P2X4 receptors.
2013,
Pubmed
,
Xenbase Priel,
Mechanism of ivermectin facilitation of human P2X4 receptor channels.
2004,
Pubmed Sattelle,
Comparative pharmacology and computational modelling yield insights into allosteric modulation of human alpha7 nicotinic acetylcholine receptors.
2009,
Pubmed
,
Xenbase Shan,
Ivermectin, an unconventional agonist of the glycine receptor chloride channel.
2001,
Pubmed Spinosa,
Possible anxiolytic effects of ivermectin in rats.
2002,
Pubmed Steensland,
Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking.
2007,
Pubmed Sung,
Avermectin intoxication with coma, myoclonus, and polyneuropathy.
2009,
Pubmed Vassilatis,
Genetic and biochemical evidence for a novel avermectin-sensitive chloride channel in Caenorhabditis elegans. Isolation and characterization.
1997,
Pubmed
,
Xenbase Yardley,
Ivermectin reduces alcohol intake and preference in mice.
2012,
Pubmed
,
Xenbase
